Kimberly Yousey-Hindes, MPH
DownloadHi-Res Photo
Cards
Titles
Program Manager, RESP-NET, Connecticut Emerging Infections Program
Contact Info
Connecticut Emerging Infections Program
One Church St
New Haven, CT 06510
United States
About
Titles
Epidemiologist 3 and Lecturer in Epidemiology (Microbial Diseases)
Program Manager, RESP-NET, Connecticut Emerging Infections ProgramBiography
Ms. Yousey-Hindes has worked in the area of infectious disease epidemiology since 2007 for the Council of State and Territorial Epidemiologists and the New York State Department of Health in addition to her current position at the Connecticut Emerging Infections Program (EIP). Within the EIP, Kim has contributed to multiple projects, especially in the area of respiratory disease surveillance. She oversees three population-based surveillance systems in Connecticut as part of CDC's RESP-NET: FluSurv-NET (influenza-associated hospitalizations), RSV-NET (respiratory syncytial virus-associated hospitalizations), and COVID-NET (COVID-19-associated hospitalizations).
Education & Training
- CDC/Council of State and Territorial Epidemiologists Fellow
- New York State Department of Public Health (2008)
- MPH
- Yale School of Public Health, Epidemiology of Microbial Diseases (2007)
- BS
- University of Rochester, Microbiology and Immunology (2004)
Research
Overview
Medical Subject Headings (MeSH)
Epidemiology; Infectious Disease Medicine; Influenza, Human; Lyme Disease; Population Surveillance; Rabies; Zoonoses
ORCID
0000-0002-9418-575X
Research at a Glance
Yale Co-Authors
Frequent collaborators of Kimberly Yousey-Hindes's published research.
Publications Timeline
A big-picture view of Kimberly Yousey-Hindes's research output by year.
Research Interests
Research topics Kimberly Yousey-Hindes is interested in exploring.
James Meek, MPH
James Hadler, MD, MPH
Laura Bothwell, PhD, MA
Robert Heimer, PhD
70Publications
5,212Citations
Influenza, Human
Population Surveillance
Lyme Disease
Rabies
Zoonoses
Publications
2024
Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection
Woodruff R, Melgar M, Pham H, Sperling L, Loustalot F, Kirley P, Austin E, Yousey-Hindes K, Openo K, Ryan P, Brown C, Lynfield R, Davis S, Barney G, Tesini B, Sutton M, Talbot H, Zahid H, Kim L, Havers F, Rowlands J, Spina N, Engesser K, Salazar-Sanchez Y, George A, Staten H, Bleecker M, Leegwater L, Tellez Nunez V, Falkowski A, Felsen C, Licherdell E, St George K, Pacheco F, Desiato J, Labozzo N, Zmek E, Alden N, Strayhorn N, Fawcett E, Surell C, Como-Sabetti K, Mumm E, Bilski K, Markus T, Ndi D, Billings K. Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection. JAMA Internal Medicine 2024, 184: 602-611. PMID: 38619857, PMCID: PMC11019447, DOI: 10.1001/jamainternmed.2024.0212.Peer-Reviewed Original ResearchCitationsAltmetricConceptsRespiratory syncytial virus infectionRespiratory syncytial virusRespiratory syncytial virus seasonAcute cardiac eventsCardiac eventsWeighted estimated prevalenceIn-hospital deathAdjusted risk ratiosIntensive care unitClassification of DiseasesCross-sectional studyHospitalized adultsCardiac complicationsRSV infectionRSV diseaseLaboratory-confirmed RSV infectionOlder adultsCases of RSV infectionReceipt of invasive mechanical ventilationCardiovascular diseaseIntensive care unit admissionSevere outcomesEstimated prevalenceAcute heart failurePotential cardiac complications
2023
412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020
Kim D, Yousey-Hindes K. 412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020. Open Forum Infectious Diseases 2023, 10: ofad500.482. PMCID: PMC10679268, DOI: 10.1093/ofid/ofad500.482.Peer-Reviewed Original ResearchConceptsAcute respiratory distress syndromeAge groupsFluSurv-NETRespiratory failureMedian lengthDischarge diagnosisPneumonia casesChest X-ray/CTIntensive care unit admissionEmerging Infections ProgramAcute respiratory failureCare unit admissionLaboratory-confirmed influenzaChronic lung diseaseRespiratory distress syndromeLonger median lengthCoronavirus disease 2019 (COVID-19) pandemicLength of stayChronic metabolic diseaseComparison of outcomesCOVID-19 hospitalizationHospitalized COVID-19COVID-19Disease 2019 pandemicSame age group740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020
Jackson K, Resler S, Nadle J, Petit S, Yousey-Hindes K, Ray S, Lynfield R, Como-Sabetti K, Bernu C, Dumyati G, Tracy M, Schaffner W, Patel K, Havers F, Biggs H, See I, See I. 740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020. Open Forum Infectious Diseases 2023, 10: ofad500.801. PMCID: PMC10677147, DOI: 10.1093/ofid/ofad500.801.Peer-Reviewed Original ResearchConceptsCOVID-19-associated hospitalizationLong-term acute care hospitalLong-term care facilitiesCentral venous cathetersMultivariable logistic regressionAcute care hospitalsVenous cathetersCare hospitalCare facilitiesISA infectionsCDC's Emerging Infections ProgramIntensive care unit admissionLogistic regressionInvasive Staphylococcus aureus infectionsEmerging Infections ProgramSurveillance area residentCare unit admissionIntensive care interventionsBody mass indexIntensive care unitStaphylococcus aureus infectionInvasive Staphylococcus aureusBackground COVID-19Grant/research supportHigh death rateSeverity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study
Sumner K, Masalovich S, O’Halloran A, Holstein R, Reingold A, Kirley P, Alden N, Herlihy R, Meek J, Yousey-Hindes K, Anderson E, Openo K, Monroe M, Leegwater L, Henderson J, Lynfield R, McMahon M, McMullen C, Angeles K, Spina N, Engesser K, Bennett N, Felsen C, Lung K, Shiltz E, Thomas A, Talbot H, Schaffner W, Swain A, George A, Rolfes M, Reed C, Garg S. Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study. The Lancet Microbe 2023, 4: e903-e912. PMID: 37769676, PMCID: PMC10872935, DOI: 10.1016/s2666-5247(23)00187-8.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInfluenza virus typeInfluenza-associated hospitalisationsInfluenza seasonInfluenza B virusICU admissionMechanical ventilationSevere outcomesOdds ratioVirus typeFluSurv-NETECMO useInfluenza vaccineB virusVirus infectionLaboratory-confirmed influenza virus infectionInfluenza Hospitalization Surveillance NetworkInfluenza B virus infectionPopulation-based surveillance systemComplete chart reviewEarly antiviral treatmentHospital-onset casesInfluenza-associated outcomesRepeated cross-sectional studyInfluenza vaccination statusB virus infection
2022
Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015–2019
Tenforde M, Cummings C, O’Halloran A, Rothrock G, Kirley P, Alden N, Meek J, Yousey-Hindes K, Openo K, Anderson E, Monroe M, Kim S, Nunez V, McMahon M, McMullen C, Khanlian S, Spina N, Muse A, Gaitán M, Felsen C, Lung K, Shiltz E, Sutton M, Thomas A, Talbot H, Schaffner W, Price A, Chatelain R, Reed C, Garg S. Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015–2019. Open Forum Infectious Diseases 2022, 10: ofac681. PMID: 36686630, PMCID: PMC9846184, DOI: 10.1093/ofid/ofac681.Peer-Reviewed Original ResearchCitationsAltmetric303. Viral and bacterial infections among adults hospitalized with COVID-19, Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, 14 states, March 2020–February 2022
Melisa S, Taylor C, Patel K, Milucky J, Whitaker M, Pham H, Anglin O, Reingold A, Armistead I, Yousey-Hindes K, Anderson E, Weigel A, Reeg L, Mumm E, Ropp S, Muse A, Bushey S, Shiltz E, Sutton M, Talbot K, Price A, Havers F. 303. Viral and bacterial infections among adults hospitalized with COVID-19, Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, 14 states, March 2020–February 2022. Open Forum Infectious Diseases 2022, 9: ofac492.381-. PMCID: PMC9751616, DOI: 10.1093/ofid/ofac492.381.Peer-Reviewed Original ResearchConceptsDay of admissionBacterial infectionsCoronavirus diseaseRelevant bacterial pathogensCOVID-19Acute respiratory syndrome coronavirus 2 infectionLaboratory-confirmed SARS-CoV-2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSyndrome coronavirus 2 infectionSARS-CoV-2 infectionSurveillance networkCommon respiratory isolatesRV/EVCoronavirus 2 infectionRhinovirus/enterovirusBronchoalveolar lavage fluidRespiratory syncytial virusBacterial pathogensCare molecular testingHospitalized adultsBacterial coinfectionClinical featuresClinical outcomesLavage fluidSyncytial virusTrends in disparities in COVID hospitalizations among community‐dwelling residents of two counties in Connecticut, before and after vaccine introduction, March 2020–September 2021
McWilliams C, Bothwell L, Yousey‐Hindes K, Hadler J. Trends in disparities in COVID hospitalizations among community‐dwelling residents of two counties in Connecticut, before and after vaccine introduction, March 2020–September 2021. Influenza And Other Respiratory Viruses 2022, 17: e13082. PMID: 36509459, PMCID: PMC9835416, DOI: 10.1111/irv.13082.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCOVID-19 hospitalizationNon-Hispanic blacksGeocoded residential addressesAge-adjusted incidenceNon-Hispanic whitesHispanic/LatinxVaccination ratesLaboratory-confirmed COVID-19Residential addressesSocioeconomic statusSurveillance Network databaseCommunity-dwelling residentsNon-institutionalized personsIntroduction of vaccinesLow socioeconomic statusCensus tract measuresRace/ethnicityLower SES groupsVaccine registryVaccine introductionVaccination levelsHospitalizationVaccine rolloutDelta wavesSES disparitiesVital Signs: Influenza Hospitalizations and Vaccination Coverage by Race and Ethnicity—United States, 2009–10 Through 2021–22 Influenza Seasons
Black C, O’Halloran A, Hung M, Srivastav A, Lu P, Garg S, Jhung M, Fry A, Jatlaoui T, Davenport E, Burns E, Network I, Network I, Reingold A, Alden N, Yousey-Hindes K, Anderson E, Ryan P, Kim S, McMahon M, Bleecker M, Spina N, Bennett N, Lung K, Sutton M, Schaffner W, Talbot H, Crossland M, Reed C, Holstein R, Ujamaa D, Cummings C. Vital Signs: Influenza Hospitalizations and Vaccination Coverage by Race and Ethnicity—United States, 2009–10 Through 2021–22 Influenza Seasons. MMWR Morbidity And Mortality Weekly Report 2022, 71: 1366-1373. PMID: 36302226, PMCID: PMC9620569, DOI: 10.15585/mmwr.mm7143e1.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInfluenza vaccination coverageBehavioral Risk Factor Surveillance SystemVaccination coverageHealth care providersInfluenza seasonInfluenza hospitalizationsInfluenza vaccinationAsian adultsCare providersHispanic adultsLaboratory-confirmed influenza-associated hospitalizationsDisease severityLow influenza vaccination coverageNon-Hispanic Asian adultsPersonal health care providerHealth care access barriersNon-Hispanic white personsRisk Factor Surveillance SystemInfluenza disease severityInfluenza hospitalization ratesPatient vaccination statusInfluenza-associated hospitalizationsPopulation-based surveillanceRoutine medical checkupVaccination coverage dataDrug use and severe outcomes among adults hospitalized with influenza, 2016–2019
Parisi C, Yousey‐Hindes K, Holstein R, O'Halloran A, Kirley P, Alden N, Anderson E, Kim S, McMahon M, Khanlian S, Spina N, Gaitan M, Shiltz E, Thomas A, Schaffner W, Talbot K, Crossland M, Cook R, Garg S, Meek J, Hadler J. Drug use and severe outcomes among adults hospitalized with influenza, 2016–2019. Influenza And Other Respiratory Viruses 2022, 17: e13052. PMID: 36300969, PMCID: PMC9835414, DOI: 10.1111/irv.13052.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSevere outcomesDrug useICU admissionMechanical ventilationInfluenza Hospitalization Surveillance NetworkInfluenza-associated outcomesSevere influenza outcomesPersistent public health problemChronic liver diseaseChronic lung diseasePublic health problemNon-Hispanic blacksLogistic regression modelsHispanics/LatinosSmoke tobaccoInfluenza vaccinationOpioid useImmunosuppressive conditionsInfluenza seasonSevere morbidityInfluenza infectionInfluenza outcomesLiver diseaseLung diseaseChronic conditionsCOVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022
Havers F, Pham H, Taylor C, Whitaker M, Patel K, Anglin O, Kambhampati A, Milucky J, Zell E, Moline H, Chai S, Kirley P, Alden N, Armistead I, Yousey-Hindes K, Meek J, Openo K, Anderson E, Reeg L, Kohrman A, Lynfield R, Como-Sabetti K, Davis E, Cline C, Muse A, Barney G, Bushey S, Felsen C, Billing L, Shiltz E, Sutton M, Abdullah N, Talbot H, Schaffner W, Hill M, George A, Hall A, Bialek S, Murthy N, Murthy B, McMorrow M. COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022. JAMA Internal Medicine 2022, 182: 1071-1081. PMID: 36074486, PMCID: PMC9459904, DOI: 10.1001/jamainternmed.2022.4299.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCOVID-19-associated hospitalizationUnderlying medical conditionsHospitalization ratesUnvaccinated personsVaccinated personsBooster doseMedical conditionsLaboratory-confirmed COVID-19-associated hospitalizationsLaboratory-confirmed SARS-CoV-2 infectionLong-term care facility residentsPositive SARS-CoV-2 test resultCOVID-19 Associated HospitalizationsDetailed medical record reviewImmunization information system dataSARS-CoV-2 test resultsCOVID-19-Associated Hospitalization Surveillance NetworkSARS-CoV-2 infectionCOVID-19Patients 18 yearsMedical record reviewCare facility residentsVaccination coverage dataAdults 18 yearsCross-sectional studyPublic health efforts
Links & Media
News
- April 09, 2020Source: YaleNews
Hospitalization for Coronavirus Highest in Connecticut Among 14 States Studied
- April 09, 2020
Hospitalization for Coronavirus Highest in Connecticut Among 14 States Studied
- March 01, 2018Source: The Washington Post
Their 6-year-old daughter was dead, killed by the flu, but the worrying was just beginning
Get In Touch
Contacts
Mailing Address
Connecticut Emerging Infections Program
One Church St
New Haven, CT 06510
United States
Locations
1 Church Street
Academic Office
Ste 7th Floor
New Haven, CT 06510